Abstract
Lymphomas occur with a greatly increased frequency among immunocompromised individuals regardless of whether the immunodeficiency is congenital, acquired as a result of HIV infection or iatrogenic as a result of anti-rejection therapy in allograft recipients. This article focuses on the differences in clinical management of these lymphomas.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
